| Panjon Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 526345 |
NSE Symbol : - |
P/E(TTM) : 39.12 |
|
ISIN Demat : INE744D01019 |
Div & Yield% : 0.00 |
EPS(TTM) : 0.43 |
|
Book Value(₹) : 9.88 |
Market Cap(₹Cr) : 28.87 |
Face Value(₹) : 10.00 |
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 14.95 | 6.42 | 13.83 | 11.16 | 3.38 | 2.09 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 14.95 | 6.42 | 13.83 | 11.16 | 3.38 | 2.09 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.05 | 0.04 | 0.05 | 0.08 | 0.08 | 0.10 |
| Total Income | 14.99 | 6.45 | 13.88 | 11.24 | 3.46 | 2.19 |
| Total Expenditure | 14.68 | 6.22 | 13.52 | 10.93 | 3.31 | 2.08 |
| PBIDT | 0.31 | 0.23 | 0.36 | 0.31 | 0.15 | 0.11 |
| Interest | 0.04 | 0.06 | 0.06 | 0.06 | 0.03 | 0.03 |
| PBDT | 0.27 | 0.17 | 0.30 | 0.25 | 0.12 | 0.09 |
| Depreciation | 0.04 | 0.08 | 0.08 | 0.05 | 0.05 | 0.05 |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Reported Profit After Tax | 0.22 | 0.09 | 0.23 | 0.20 | 0.07 | 0.03 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 0.22 | 0.09 | 0.23 | 0.20 | 0.07 | 0.03 |
| EPS (Unit Curr.) | 0.01 | 0.06 | 0.13 | 0.11 | 0.00 | 0.02 |
| EPS (Adj) (Unit Curr.) | 0.01 | 0.06 | 0.13 | 0.11 | 0.00 | 0.02 |
| Calculated EPS (Unit Curr.) | 0.13 | 0.06 | 0.13 | 0.12 | 0.04 | 0.02 |
| Calculated EPS (Adj) (Unit Curr.) | 0.13 | 0.06 | 0.13 | 0.12 | 0.04 | 0.02 |
| Calculated EPS (Ann.) (Unit Curr.) | 0.52 | 0.22 | 0.53 | 0.47 | 0.16 | 0.08 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 0.52 | 0.22 | 0.53 | 0.47 | 0.16 | 0.08 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 17.16 | 17.16 | 17.16 | 17.16 | 17.16 | 16.31 |
| Reserve & Surplus | -0.30 | -0.53 | -0.62 | -1.46 | -1.46 | -1.46 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 2.07 | 3.58 | 2.60 | 2.78 | 4.44 | 5.26 |
| PBDTM(%) | 1.81 | 2.65 | 2.17 | 2.24 | 3.55 | 4.31 |
| PATM(%) | 1.47 | 1.40 | 1.66 | 1.79 | 2.07 | 1.44 |